학술논문
The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alström syndrome: Phase 3 trial design
Document Type
Article
Author
Source
In Contemporary Clinical Trials Communications June 2021 22
Subject
Language
ISSN
2451-8654